weekly · 2026-11-02 — 2026-11-08
Early optical production and equipment progress leave supply dependencies unresolved
InnoLight and Tower report early NPO-device production, while Chinese equipment suppliers disclose progress across production and customer validation. Material shortages, foreign fabrication and tool dependencies, and YMTC’s financing pause qualify the expansion story. No dated forecast changed.
Published 2026-11-09 · Evidence through 2026-11-08 · Completed period
Early NPO production still relies on an overseas fab
Tower and InnoLight announced on November 3 that their first near-package-optics device had entered early production on Tower’s PH18M platform at its California fab; additional products were planned for 300 mm tape-outs. This is a specific manufacturing milestone with a named overseas dependency, without disclosed production volume, yield or customer acceptance. InnoLight’s separate investor disclosure expected NPO demand to begin ramping in the second half of 2027, with more demand in 2028. Early device production and a future module-demand ramp describe different stages. Management identified manufacturing yields and upstream light-source and electronic-chip readiness as work still required.
InnoLight (filing hosted by Sina) · InnoLight outlines NPO yield requirements and supply outlook (source)Tower Semiconductor · InnoLight NPO device enters early production at Tower California fab (source)Optical order visibility does not remove material constraints
In its November 6 disclosure, InnoLight said major-customer orders broadly covered 2027 and some customers had provided 2028 demand guidance. It described long-term supply agreements, prepayments and additional suppliers as responses to shortages of critical materials. The company again expected next-generation NPO/XPO demand from the second half of 2027. These are management statements about demand and supply preparation, not verified accepted shipments or assured component availability. Supplier identities, secured quantities and qualified capacity remain undisclosed; stronger order visibility therefore does not establish a self-sufficient supply chain.
InnoLight · 关于股份回购事项的公告(含经营情况及未来展望) (source)Equipment progress spans production, acceptance and validation
AMEC’s investor record published November 2 says its 60:1 high-aspect-ratio etcher is in volume production with uptime above 90%, while its 90:1 successor remains in customer validation. It reports a 140:1 Angnova etch result and shipment for customer certification, plus cumulative tungsten-deposition shipments exceeding 500 reaction stations—not 500 complete tools or accepted installations. These are vendor claims without independent uptime methodology or production economics. Separately, November 5 reporting on Hwatsing’s management discussion describes bulk deliveries and repeat orders for high-current ion implantation and customer acceptance of multiple thinning tools; medium-current implantation and metrology remain in validation. These stages should not be collapsed into qualified HBM production capacity.
AMEC (filing hosted by Sina Finance) · 2026年10月投资者关系活动记录表 (source)STAR Market Daily / CLS (Sina republication) · Hwatsing reports thinning acceptance and ion-implantation repeat orders (source)YMTC’s domestic-tool ambition faces financing uncertainty
Reuters reported November 6 that YMTC targets at least 60% domestic equipment, potentially 70%, at a planned fourth Wuhan factory. Construction is expected in 2027; supplier talks are preliminary, with no formal orders. Foreign lithography and inspection dependencies remain. Separately, Reuters reported November 4 that YMTC’s IPO process was on hold amid weaker markets, citing sources and a memo. Neither report establishes cancellation of the factory. Together they make financing, actual tool orders and qualification the next tests of planned capacity; a sourcing target alone does not prove a sovereign production flow.
Reuters · YMTC reportedly targets higher domestic equipment share (source)Reuters · YMTC listing reportedly delayed (source)Iluvatar reports shipment scale, with operating evidence still missing
November 2 reporting on Iluvatar’s voluntary announcement puts January–October chip shipments above 80,000. The figure is unaudited and may be adjusted. It concerns an earlier operating period and does not disclose product mix, customer-accepted installations, utilization or matched workload performance. Shipment scale is commercially relevant, but it cannot establish training time-to-quality, inference efficiency or frontier parity. The original exchange filing remains a follow-up retrieval gap for this briefing.
Sina Hong Kong Stocks · Iluvatar voluntary shipment update: more than 80,000 chips in ten months (source)Forecasts unchanged; benchmark verification remains limited
No dated Observatory forecast changes. The optical-development horizon through 2028, the 2027–2030 HBM/advanced-packaging horizon and the late-2020s frontier-pretraining judgment remain intact. Watch for accepted NPO deliveries, disclosed material availability, validated equipment at production scale, YMTC financing and formal orders, and accelerator deployments with reproducible operating data. Post-period context: November 9 checks did not verify a new matched contemporary Chinese frontier end-to-end comparison. MLPerf repository-head checks were not an exhaustive result-artifact audit. The retrieved InferenceX page carried an unofficial-deployment warning that its data could be modified or outdated, so it was not accepted as authoritative new benchmark evidence. This is a limitation of verification, not proof that no qualifying result exists; historical measured evidence remains preserved.
SemiAnalysis · Continuous inference benchmark dashboard (source)InnoLight (filing hosted by Sina) · InnoLight outlines NPO yield requirements and supply outlook (source)MLCommons · MLPerf Inference v6.1 closed submissions (source)MLCommons · MLPerf Training v6.0 submissions (source)Reuters · YMTC reportedly targets higher domestic equipment share (source)